341 related articles for article (PubMed ID: 30792074)
1. Risk Factors of QTc Prolongation in Women With Hormone Receptor‒positive/Human Epidermal Growth Factor Receptor 2‒negative Metastatic Breast Cancer: A Retrospective Analysis of Health Care Claims Data.
Ward M; Harnett J; Bell TJ; Mardekian J
Clin Ther; 2019 Mar; 41(3):494-504.e1. PubMed ID: 30792074
[TBL] [Abstract][Full Text] [Related]
2. QTc Prolongation Associated With Psychiatric Medications: A Retrospective Cross-Sectional Study of Adult Inpatients.
Shao W; Ayub S; Drutel R; Heise WC; Gerkin R
J Clin Psychopharmacol; 2019; 39(1):72-77. PubMed ID: 30531476
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients.
Al-Azayzih A; Al-Qerem W; Al-Azzam S; Muflih S; Al-Husein BA; Kharaba Z; Kanaan RJ; Rahhal D
Vasc Health Risk Manag; 2024; 20():27-37. PubMed ID: 38318252
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of QT interval prolongation in inflammatory bowel disease.
Pattanshetty DJ; Gajulapalli RD; Anna K; Sappati Biyyani RS
Turk J Gastroenterol; 2016 Mar; 27(2):136-42. PubMed ID: 26853794
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
6. Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
Salem JE; Dureau P; Bachelot A; Germain M; Voiriot P; Lebourgeois B; Trégouët DA; Hulot JS; Funck-Brentano C
JAMA Cardiol; 2018 Sep; 3(9):877-882. PubMed ID: 30073300
[TBL] [Abstract][Full Text] [Related]
7. Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study.
Lazzerini PE; Cevenini G; Qu YS; Fabris F; El-Sherif N; Acampa M; Cartocci A; Laghi-Pasini F; Capecchi PL; Boutjdir M; Lazaro D
J Am Heart Assoc; 2021 Feb; 10(4):e018735. PubMed ID: 33533258
[TBL] [Abstract][Full Text] [Related]
8. Population-based study of QT interval prolongation in patients with rheumatoid arthritis.
Chauhan K; Ackerman MJ; Crowson CS; Matteson EL; Gabriel SE
Clin Exp Rheumatol; 2015; 33(1):84-9. PubMed ID: 25572282
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study.
Ali Z; Ismail M; Nazar Z; Khan F; Khan Q; Noor S
BMC Psychiatry; 2020 Jun; 20(1):277. PubMed ID: 32493330
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study.
Yuan N; Oesterle A; Botting P; Chugh S; Albert C; Ebinger J; Ouyang D
JMIR Cardio; 2023 Jan; 7():e41055. PubMed ID: 36662566
[TBL] [Abstract][Full Text] [Related]
11. Drug-Induced QTc Prolongation.
Riad FS; Davis AM; Moranville MP; Beshai JF
Am J Cardiol; 2017 Jan; 119(2):280-283. PubMed ID: 28126150
[TBL] [Abstract][Full Text] [Related]
12. Drugs and ventricular repolarization in a general population: the Rotterdam Study.
Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.
Benoit SR; Mendelsohn AB; Nourjah P; Staffa JA; Graham DJ
Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):363-8. PubMed ID: 16079644
[TBL] [Abstract][Full Text] [Related]
14. Incidence and outcomes of long QTc in acute medical admissions.
Mahmud R; Gray A; Nabeebaccus A; Whyte MB
Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.
Porta-Sánchez A; Gilbert C; Spears D; Amir E; Chan J; Nanthakumar K; Thavendiranathan P
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217664
[TBL] [Abstract][Full Text] [Related]
16. Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012.
Swallow E; Zhang J; Thomason D; Tan RD; Kageleiry A; Signorovitch J
Curr Med Res Opin; 2014 Aug; 30(8):1537-45. PubMed ID: 24669852
[TBL] [Abstract][Full Text] [Related]
17. QTc prolongation in children following congenital cardiac disease surgery.
Punn R; Lamberti JJ; Balise RR; Seslar SP
Cardiol Young; 2011 Aug; 21(4):400-10. PubMed ID: 21362209
[TBL] [Abstract][Full Text] [Related]
18. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.
Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD
HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263
[TBL] [Abstract][Full Text] [Related]
19. Life-threatening cardiac arrhythmias due to drug-induced QT prolongation : A retrospective study over 6 years from a medical intensive care unit.
Michels G; Kochanek M; Pfister R
Med Klin Intensivmed Notfmed; 2016 May; 111(4):302-9. PubMed ID: 26340799
[TBL] [Abstract][Full Text] [Related]
20. Beat-to-beat corrected QT analysis detects corrected QT prolongation in 50 consecutive telemetry-monitored patients.
Davidson JE; Agan D; Ballard DL; Truong HT; Bridgen CM; Rubino S; Sikand H; Stein J
J Cardiovasc Nurs; 2013; 28(6):584-90. PubMed ID: 22990234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
